NCT03895593 Rescue Fecal Microbiota Transplantation for National Refractory Intestinal Infections
| NCT ID | NCT03895593 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Second Hospital of Nanjing Medical University |
| Condition | Intestinal Infection |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2015-09-25 |
| Primary Completion | 2024-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2015-09-25 with a primary completion date of 2024-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A national data registry of patients receiving the rescue fecal microbiota transplantation for the refractory intestinal infections from the China Microbiota Transplantation System was designed to assess the short-term and long-term safety and efficacy.
Eligibility Criteria
Inclusion Criteria: National patients with refractory intestinal infections receiving rescue FMT from the China Microbiota Transplantation System from September 2015 to December, 2029 will be included. \- Exclusion Criteria: Patients will be excluded from the analysis if they are not followed up for at least 12 weeks post-FMT. \-
Contact & Investigator
faming zhang, MD,PhD
PRINCIPAL INVESTIGATOR
The Second Hospital of Nanjing Medical University
Frequently Asked Questions
Who can join the NCT03895593 clinical trial?
This trial is open to participants of all sexes, studying Intestinal Infection. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03895593 currently recruiting?
Yes, NCT03895593 is actively recruiting participants. Contact the research team at fzhang@njmu.edu.cn for enrollment information.
Where is the NCT03895593 trial being conducted?
This trial is being conducted at Nanjing, China.
Who is sponsoring the NCT03895593 clinical trial?
NCT03895593 is sponsored by The Second Hospital of Nanjing Medical University. The principal investigator is faming zhang, MD,PhD at The Second Hospital of Nanjing Medical University. The trial plans to enroll 100 participants.